+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bloodstream Infection Testing Market by Product (Instruments, Reagents & Kits, Software), Technology (Biosensor Platforms, Culture Based Systems, Mass Spectrometry), End User, Application - Global Forecast 2025-2030- Product Image
Bloodstream Infection Testing Market by Product (Instruments, Reagents & Kits, Software), Technology (Biosensor Platforms, Culture Based Systems, Mass Spectrometry), End User, Application - Global Forecast 2025-2030- Product Image
Sale

Bloodstream Infection Testing Market by Product (Instruments, Reagents & Kits, Software), Technology (Biosensor Platforms, Culture Based Systems, Mass Spectrometry), End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977727
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bloodstream Infection Testing Market is rapidly evolving, as healthcare systems face rising complexity from antimicrobial resistance and hospitals prioritize faster, more precise diagnostics. Senior leaders in diagnostics, procurement, and laboratory management will find this market driven by the convergence of enhanced testing protocols, digital integration, and new compliance demands.

Market Snapshot: Bloodstream Infection Testing Market Growth and Opportunity

The Bloodstream Infection Testing Market grew from USD 1.20 billion in 2024 to USD 1.30 billion in 2025. It is expected to continue growing at a CAGR of 7.73%, reaching USD 1.88 billion by 2030. This sustained expansion reflects greater clinical urgency in reliably identifying bloodstream pathogens and managing infection-related costs. Innovation and collaboration are transforming core offerings, allowing for the integration of comprehensive diagnostic platforms in advanced and emerging economies alike. As value-based healthcare takes precedence, hospitals and laboratory networks are adopting more interconnected and efficient solutions.

Scope & Segmentation: Comprehensive Coverage Across Technology, Platform, and Geography

  • Product: Instruments, Reagents & Kits, Software.
  • Technology: Biosensor Platforms (including Electrochemical and Optical Biosensors), Culture Based Systems (Automated Culture Systems, Manual Culture Methods), Mass Spectrometry (MALDI ToF Ms), and Molecular Diagnostics (Next Generation Sequencing, PCR).
  • End User: Academic & Research Institutes, Hospital Laboratories, Point Of Care Testing, Reference Laboratories.
  • Application: Clinical Diagnosis, Research, Surveillance & Monitoring.
  • Region: Americas (including United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Becton Dickinson and Company, bioMérieux SA, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Inc., Luminex Corporation, QIAGEN N.V.

Key Takeaways for Senior Decision-Makers

  • The shift toward molecular diagnostics and digital workflow integration is streamlining lab operations, supporting faster, more actionable results across multiple clinical settings.
  • Automated systems and biosensor technologies are reducing manual intervention, increasing throughput, and enhancing detection of emerging pathogens—addressing operational challenges for both large reference labs and decentralized care environments.
  • Regulatory shifts are attaching a higher premium to clinical efficacy and cost-effectiveness, making real-world data and robust post-market surveillance essential for diagnostics providers and purchasers.
  • Strategic partnerships between academic centers, global tech firms, and local distributors are unlocking new avenues for co-development and rapid market entry, especially in regions with evolving healthcare infrastructure needs.
  • Broader pathogen panels, real-time reporting, and AI-powered data analytics are now central to antimicrobial stewardship and improved patient outcomes in both acute and community settings.

Tariff Impact: Navigating 2025 United States Supply Chain Shifts

The United States tariff adjustments in 2025 have prompted supply chain reconfiguration among manufacturers and healthcare providers. Increased tariffs on diagnostic reagents, instruments, and consumables have driven a recalibration in sourcing, with organizations seeking alternative suppliers, deeper local alliances, and new procurement models such as reagent rentals and pay-per-test agreements. These tariff factors are requiring a more agile approach to procurement, cost management, and vendor negotiation within hospital labs and diagnostic networks.

Methodology & Data Sources

This report leverages a dual-method research approach, combining firsthand interviews with laboratory directors, clinical experts, and regulatory specialists, alongside analysis from peer-reviewed literature and leading industry publications. Quantitative findings are cross-validated using proprietary databases, expert review sessions, and market mapping to deliver credible, actionable insights.

Why This Report Matters

  • Enables hospital leaders and procurement executives to benchmark diagnostic portfolios and inform future investment priorities across evolving technology modalities.
  • Supports strategic planning by detailing competitive moves, regulatory trends, and segmentation-specific opportunities for market entry and expansion.

Conclusion

As global demand for efficient bloodstream infection diagnostics accelerates, organizations equipped with responsive supply chains, advanced platforms, and robust data strategies will be positioned to deliver significant clinical and operational value. This report provides a structured foundation for confidently navigating market transformation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of next-generation sequencing platforms for rapid pathogen identification in bloodstream infection diagnostics
5.2. Emergence of antimicrobial resistance profiling assays to guide personalized antibiotic therapy in sepsis patients
5.3. Adoption of point-of-care molecular diagnostic devices to accelerate bloodstream infection detection in critical care settings
5.4. Development of multiplex immunoassay panels for simultaneous detection of bacterial and fungal pathogens in blood infections
5.5. Implementation of digital health platforms for remote monitoring and data integration in bloodstream infection management
5.6. Advancements in microfluidic lab-on-a-chip technologies for automated pathogen enrichment and identification from blood samples
5.7. Regulatory incentives and reimbursement reforms driving adoption of novel diagnostics for bloodstream infection testing in hospitals
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bloodstream Infection Testing Market, by Product
8.1. Introduction
8.2. Instruments
8.3. Reagents & Kits
8.4. Software
9. Bloodstream Infection Testing Market, by Technology
9.1. Introduction
9.2. Biosensor Platforms
9.2.1. Electrochemical Biosensors
9.2.2. Optical Biosensors
9.3. Culture Based Systems
9.3.1. Automated Culture Systems
9.3.2. Manual Culture Methods
9.4. Mass Spectrometry
9.4.1. MALDI ToF Ms
9.5. Molecular Diagnostics
9.5.1. Next Generation Sequencing
9.5.2. PCR
10. Bloodstream Infection Testing Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospital Laboratories
10.4. Point Of Care Testing
10.5. Reference Laboratories
11. Bloodstream Infection Testing Market, by Application
11.1. Introduction
11.2. Clinical Diagnosis
11.3. Research
11.4. Surveillance & Monitoring
12. Americas Bloodstream Infection Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bloodstream Infection Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bloodstream Infection Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Becton Dickinson and Company
15.3.2. bioMérieux SA
15.3.3. F. Hoffmann-La Roche AG
15.3.4. Thermo Fisher Scientific Inc.
15.3.5. Siemens Healthineers AG
15.3.6. Abbott Laboratories
15.3.7. Danaher Corporation
15.3.8. Bio-Rad Laboratories, Inc.
15.3.9. Luminex Corporation
15.3.10. QIAGEN N.V.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOODSTREAM INFECTION TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BLOODSTREAM INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BLOODSTREAM INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BLOODSTREAM INFECTION TESTING MARKET: RESEARCHAI
FIGURE 24. BLOODSTREAM INFECTION TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. BLOODSTREAM INFECTION TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. BLOODSTREAM INFECTION TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BLOODSTREAM INFECTION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ELECTROCHEMICAL BIOSENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ELECTROCHEMICAL BIOSENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY OPTICAL BIOSENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY OPTICAL BIOSENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MANUAL CULTURE METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MANUAL CULTURE METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MALDI TOF MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MALDI TOF MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SURVEILLANCE & MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SURVEILLANCE & MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 104. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 105. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 106. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 107. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 108. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 109. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 110. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 111. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 112. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 113. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 114. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 115. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 120. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 121. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 128. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 129. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 202. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 203. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 210. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 211. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 218. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 219. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 226. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 227. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 250. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 251. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 254. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 255. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 256. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 257. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 258. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 259. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 260. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 261. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 266. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 267. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 270. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 271. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 274. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 275. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2025

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Bloodstream Infection Testing market report include:
  • Becton Dickinson and Company
  • bioMérieux SA
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Luminex Corporation
  • QIAGEN N.V.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.88 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bloodstream Infection Testing - Global Strategic Business Report - Product Image

Bloodstream Infection Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Blood Culture Test Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User - Product Image

Blood Culture Test Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

  • Report
  • 142 Pages
  • Global
From
Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2025-2033 - Product Image

Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2025-2033

  • Report
  • 146 Pages
  • Global
From
Blood Stream Infection Testing Market Report 2025 - Product Image

Blood Stream Infection Testing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Blood Culture Tests - Global Strategic Business Report - Product Image

Blood Culture Tests - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From

About the Bloodstream Infection Test Market

The Bloodstream Infection Test market is a subset of the larger Infectious Disease Testing market. It is used to detect the presence of bacteria, fungi, and viruses in the bloodstream. The test is typically performed on a sample of blood taken from a patient, and the results are used to diagnose and treat infections. The test can also be used to monitor the effectiveness of treatments. The Bloodstream Infection Test market is highly competitive, with a range of products available from different manufacturers. These products vary in terms of accuracy, cost, and turnaround time. The market is also subject to regulatory requirements, which can affect the availability of certain products. Some companies in the Bloodstream Infection Test market include Abbott, Becton Dickinson, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.